Incepta Pharma Llp - Company Profile

It is a pharma limited liability partnership based in Nagpur, Maharashtra, India, established in 2017.
2017 Nagpur, Maharashtra, India Active
Last Updated:
Access Report
About Incepta Pharma Llp

Incepta Pharma Llp, a active limited liability partnership, was established on 24 July 2017 in Nagpur, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAK-1066. Registered under ROC Roc Nagpur. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Samir Deodatta Sawwalakhe (Designated Partner), Vinod Madanlal Chandak (Designated Partner), Pradeep Joseph Subramani (Designated Partner). Past directors included Devendra Shobharam Turkar. Its latest date of accounts and solvency statement 31 March 2025. It is based at Flat No. 604, Jayanti Mansion, 3 Pn2 Manish Nagar, Manish Nagar, Somalwada,, Nagpur, Maharashtra, 440015.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAK-1066

  • Incorporation Date

    24 July 2017

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Nagpur

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 8 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Incepta Pharma Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Incepta Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Incepta Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Samir Deodatta Sawwalakhe Designated Partner 24 Jul 2017 Current
Vinod Madanlal Chandak Designated Partner 20 Aug 2024 Current
Pradeep Joseph Subramani Designated Partner 24 Jul 2017 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 20 Aug 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Incepta Pharma Llp.

Enhance accessibility to Incepta Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Incepta Pharma Llp revenue growth over time
Incepta Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Incepta Pharma Llp?

Unlock access to Incepta Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Incepta Pharma Llp?

Unlock and access historical data on people associated with Incepta Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Incepta Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Incepta Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Incepta Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    Incepta Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    Incepta Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Nagpur. was recorded as a recent event.

  • Director Appointment

    Vinod Madanlal Chandak was appointed as a Designated Partner was appointed as a Designated Partner on 20 Aug 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.

  • Director Appointment

    The activity Samir Deodatta Sawwalakhe was appointed as a Designated Partner was appointed as a Designated Partner on 24 Jul 2017 & has been associated with this company since 8 years 9 months . was completed.

  • Director Appointment

    The activity Pradeep Joseph Subramani was appointed as a Designated Partner was appointed as a Designated Partner on 24 Jul 2017 & has been associated with this company since 8 years 9 months . was completed.

  • LLP Incorporation

    Incepta Pharma Llp was registered on 24 Jul 2017 with Roc Nagpur & aged 8 years 9 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Incepta Pharma Llp?

The LLPIN of Incepta Pharma Llp is AAK-1066.

Where is Incepta Pharma Llp headquartered?

Incepta Pharma Llp is headquartered at Flat No. 604, Jayanti Mansion, 3 Pn2 Manish Nagar, Manish Nagar, Somalwada,, Nagpur, Maharashtra, 440015.

When was Incepta Pharma Llp incorporated?

Incepta Pharma Llp was incorporated on 24 July 2017.

Who are the current directors of Incepta Pharma Llp?

The current directors of Incepta Pharma Llp are

What is the primary industry of Incepta Pharma Llp?

The primary industry of Incepta Pharma Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available